| Serial Number | 86266109 |
| Word Mark | SAFETYMAP |
| Filing Date | Tuesday, April 29, 2014 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, April 8, 2022 |
| Registration Number | 4820587 |
| Registration Date | Tuesday, September 29, 2015 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 14, 2015 |
| Goods and Services | Medical and clinical laboratory apparatus and instruments for next generation sequencing of genomic DNA for the purpose of cancer diagnostic molecular testing, in particular, cancer genomic testing and testing of genomic changes, and related automated decision support tools for diagnostic and therapeutic application, namely, computer application software and hardware for use with the laboratory apparatus and instruments |
| Pseudo Mark | SAFETY MAP |
| Goods and Services | Providing online databases featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options, in particular in the field of clinical diagnostics and therapy, in particular in the field of cancer diagnostics and cancer therapy; medical consulting services with respect to the treatment and diagnosis of individuals with cancer in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; medical consulting services in the fields of patient treatments and treatment protocols for cancer |
| Goods and Services | Data collection for scientific research, analytical and clinical purposes, in particular the collection and systematic sorting of patient's specific molecular, genomic and/or clinical data, in particular relating to genomic changes, in particular relating to cancer genomic changes; providing medical research information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; scientific clinical studies in the field of medicine; data collection for scientific research and analytical purposes, in particular the collection of mathematical and statistical data, clinical data, patient's genomic data and data of clinical studies relating to patient's clinical responses to drug treatments and treatment regimes; compiling data for research and analytical purposes in the field of medical science and diagnostics, in particular compiling patient specific molecular and genomic data, in particular cancer genomic data; scientific, technical and research services, namely, scientific, technical and medical research for medical purposes in the field of medical diagnostic and optimization of treatment regimes; providing medical and scientific research information and scientific research consulting in the fields of pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and interpretation of analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of data obtained from cancer patients, specifically patient's genomic changes that contribute to a patient's unique cancer disease; providing an online database featuring medical, pharmaceutical, biological and genomic scientific research information for medical and diagnostic purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic scientific research information for scientific research, analytical and clinical purposes; providing an online searchable database featuring scientific research in the fields of cancer medicine, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient's specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment, in particular in the field of cancer diagnosis and therapy; design and development of databases featuring biomarker data; providing an online searchable database featuring scientific research information in the fields of analysis and optimization of protocols used in cancer treatment, for medical, diagnostic and clinical use; Software as a Service (SAAS) services featuring software for providing information for patient's treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, in particular designing and conducting scientific research drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others; providing pharmaceutical scientific and medical research information, in particular research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals; providing an on-line, non-downloadable computer platform for purposes of storing and providing information about patient's individual cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, April 8, 2022 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, April 8, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, April 8, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Molecular Health GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Heidelberg 69115 DE |
| Party Name | Molecular Health GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Heidelberg 69115 DE |
| Party Name | Molecular Health GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Heidelberg 69115 DE |
| Event Date | Event Description |
| Friday, April 8, 2022 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, September 29, 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, September 29, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 14, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 14, 2015 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 24, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 26, 2015 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Monday, May 11, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, May 7, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 15, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 15, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 8, 2015 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, March 16, 2015 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, March 16, 2015 | LETTER OF SUSPENSION E-MAILED |
| Monday, March 16, 2015 | SUSPENSION LETTER WRITTEN |
| Monday, February 23, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 23, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 16, 2015 | ASSIGNED TO LIE |
| Thursday, February 12, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 9, 2015 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, February 9, 2015 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, August 13, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 13, 2014 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 13, 2014 | NON-FINAL ACTION WRITTEN |
| Monday, August 11, 2014 | ASSIGNED TO EXAMINER |
| Wednesday, May 14, 2014 | NOTICE OF PSEUDO MARK E-MAILED |
| Tuesday, May 13, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, May 2, 2014 | NEW APPLICATION ENTERED IN TRAM |